Fosun Pharma Overview

  • Founded
  • 1994
Founded
  • Status
  • Public
  • Employees
  • 32,258
Employees
  • Stock Symbol
  • 600196
Stock Symbol
  • Investments
  • 60
  • Share Price
  • $6.57
  • (As of Friday Closing)

Fosun Pharma General Information

Description

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains three business segments, including Pharmaceutical manufacturing and R&D, Healthcare services, and Manufacturing of medical diagnosis and medical devices. Most of the company's revenue is generated by its Pharmaceutical manufacturing and R&D operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Primary Office
  • Number 1289 Yishan Road
  • Building A, Fosun Technology Park
  • Shanghai, 200233
  • China
+86 021 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fosun Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.57 $6.21 $4.17 - $11.42 $15.8B 2.56B 26.3M $0.21

Fosun Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 22,370,136 22,370,136 12,148,353 11,285,256
Revenue 4,386,842 4,386,842 4,136,996 3,766,775
EBITDA 1,016,906 1,016,906 996,557 859,162
Net Income 530,181 530,181 480,722 409,344
Total Assets 12,809,148 12,809,148 10,879,208 10,256,049
Total Debt 3,675,753 3,675,753 3,131,095 3,400,823
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fosun Pharma Executive Team (17)

Name Title Board Seat Contact Info
Wu Yifang Executive Director, President & Chief Executive Officer
Wu Aryl President
Guan Xiaohui Senior Vice President & Chief Financial Officer
Shaochuan Zeng Chief Operating Officer
Yuejian Zhang General Manager
You’re viewing 5 of 17 executive team members. Get the full list »

Fosun Pharma Board Members (1)

Name Representing Role Since
0000 0000 Self Chairman 000 0000
To view Fosun Pharma’s complete board members history, request access »

Fosun Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fosun Pharma Investments & Acquisitions (60)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 26-Mar-2021 00000 00000 00 00000 Drug Discovery
00000000000000 22-Dec-2020 00000 00000 00 000.00 Biotechnology
0000000000 02-Dec-2020 00 000000000000000 0000 Therapeutic Devices
000000000 07-Sep-2020 00000 00000 00 000.00 Surgical Devices
Hinova Pharmaceuticals 24-Aug-2020 Later Stage VC 0000 Pharmaceuticals
You’re viewing 5 of 60 investments and acquisitions. Get the full list »

Fosun Pharma Subsidiaries (16)

Company Name Industry Location Founded
XingMeiShengWu Biotechnology Tianjin, China 2020
00000000000 000000 Media and Information Services (B2B) Shanghai, China 0000
0000 0000000000000 Pharmaceuticals Shanghai, China 0000
000000 0000000 Therapeutic Devices Taipei, Taiwan 0000
00000 0000000000 0 Acquirer Central, Hong Kong 0000
You’re viewing 5 of 16 subsidiaries. Get the full list »

Fosun Pharma Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000 000000 01-Apr-2018 00000 00000 00 000.00 Completed
  • 2 buyers
00000 000000000000 01-Sep-2017 000000000 00000000 000.00 Completed
  • 00000 000000
00000 03-Aug-2016 00000 00000 00 0000 Completed
  • 8 buyers
00000-000 19-Feb-2015 0000 0000 Completed
  • 4 buyers
Dian Diagnostics 29-Sep-2009 Later Stage VC 000.00 Completed
  • 2 buyers
To view Fosun Pharma’s complete exits history, request access »